Bevacizumab and small intestinal obstruction Patient Reports February 10, 2012

Bevacizumab Side Effects Report #6086391-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 13, 2009. Female patient, weighting 122.2 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain

, large intestine perforation, small intestinal obstruction. Bevacizumab dosage: 5 MG/KG, DAYS 1+15. During the same period patient was treated with FLUOROURACIL, METOPROLOL SUCCINATE, WARFARIN, MORPHINE, ONDANSETRON, PROMETHAZINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6102460-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 25, 2009. Female patient, weighting 122.2 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain

, large intestine perforation, small intestinal obstruction. Bevacizumab dosage: 5 MG/KG, DAYS 1+15. During the same period patient was treated with FLUOROURACIL, METOPROLOL SUCCINATE, WARFARIN, MORPHINE, ONDANSETRON, PROMETHAZINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5043213-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 03, 2006. Male patient, weighting 176.0 lb, was diagnosed with pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain

, diarrhoea, dyspnoea, enteritis, febrile neutropenia, pyrexia, small intestinal obstruction. Bevacizumab dosage: 400 MG QS Q2WEEKS IV. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, VICODIN, IMODIUM. Patient recovered.

Bevacizumab Side Effects Report #5082186-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2006. Male patient, weighting 176.0 lb, was diagnosed with pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, enteritis, febrile neutropenia, small intestinal obstruction. Bevacizumab dosage: 400 MG GE Q 2 WEEKS IV. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN, VICODIN, IMODIUM, ATIVAN, LISONOPRIL, NORVASC. Patient recovered.

Bevacizumab Side Effects Report #5812192-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 01, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain

, neuropathy peripheral, small intestinal obstruction. Bevacizumab dosage: 425 MG, UNK. During the same period patient was treated with CARBOPLATIN, TAXOL, HALOPERIDOL, OXYCODONE, DOCUSATE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5945651-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 24, 2008. Female patient was diagnosed with ovarian epithelial cancer, ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: unknown. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, MEDROXYPROGESTERONE, PREMARIN, AMITRIPTYLINE, SPIRONOLACTONE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5957385-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 06, 2008. Female patient was diagnosed with ovarian epithelial cancer, ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: intestinal obstruction, small intestinal obstruction. Bevacizumab dosage: 442 MG, Q3W. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, ACETAMINOPHEN, TRAMADOL, MEDROXYPROGESTERONE, PREMARIN, AMITRIPTYLINE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5991132-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 27, 2008. Female patient was diagnosed with ovarian epithelial cancer, ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: intestinal obstruction, small intestinal obstruction, vomiting. Bevacizumab dosage: 442 MG, Q3W. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, ACETAMINOPHEN, TRAMADOL, MEDROXYPROGESTERONE, PREMARIN, AMITRIPTYLINE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6065604-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 20, 2009. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain

, neuropathy peripheral, small intestinal obstruction. Bevacizumab dosage: 425 MG, UNK. During the same period patient was treated with CARBOPLATIN, TAXOL, HALOPERIDOL, OXYCODONE, DOCUSATE, LANSOPRAZOLE, DEXAMETHASONE, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5518937-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 14, 2007. Female patient, weighting 161.6 lb, was diagnosed with ovarian cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 10 MG/KG Q OTHER WK IV DRIP. During the same period patient was treated with TOPOTECAN GSK, HYDROMORPHONE, HEPARIN, NICOTINE, METHADONE, LORAZEPAM, PROMETHAZINE, CHLORASEPTIC SPRAY. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6009192-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 09, 2008. Female patient, weighting 151.0 lb, was diagnosed with ovarian cancer recurrent, neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 10 MG/KG, Q21D. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, CITALOPRAM, AMBIEN, LIPITOR, TRAZODONE, HYDROXYZINE, ALOXI. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5546335-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 06, 2007. Female patient, 31 years of age, weighting 161.6 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hydronephrosis, inadequate analgesia, sepsis

, small intestinal obstruction. Bevacizumab dosage: 10 MG/KG IV DRIP. During the same period patient was treated with TOPOTECAN GSK, ACETAMINOPHEN, BISCODYL, DILAUDID, BUPIVACAINE, DIPHENHYDRAMINE, ERTAPENEM, ESTRADIOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5557745-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 06, 2007. Female patient, 31 years of age, weighting 161.6 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hydronephrosis, malignant neoplasm progression, ovarian cancer, pain

, sepsis

, small intestinal obstruction. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with TOPOTECAN, DILAUDID, ACETAMINOPHEN, BISACODYL, DIPHENHYDRAMINE, ERTAPENEM, FAT EMULSION, FENTANYL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5396745-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 18, 2007. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with PACLITAXEL, CISPLATIN, ACETAMINOPHEN, AMBIEN, ESCITALOPRAM OXALATE, HYDROMORPHONE, IBUPROFEN, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5407506-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 26, 2007. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with PACLITAXEL, CISPLATIN, ACETAMINOPHEN, AMBIEN, ESCITALOPRAM OXALATE, HYDROMORPHONE, IBUPROFEN, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5411163-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 01, 2007. Female patient, weighting 192.0 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with ABRAXANE, LORATADINE, TRICOR, ZOFRAN, PRILOSEC, BUSPIRONE, COLACE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5446675-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 29, 2007. Female patient, weighting 192.0 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with ABRAXANE, LORATADINE, TRICOR, ZOFRAN, PRILOSEC, BUSPIRONE, COLACE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5454067-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 05, 2007. Female patient, weighting 192.0 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with ABRAXANE, LORATADINE, TRICOR, ZOFRAN, PRILOSEC, BUSPIRONE, COLACE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5470174-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 05, 2007. Female patient, weighting 192.0 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with ABRAXANE, LORATADINE, TRICOR, ZOFRAN, PRILOSEC, BUSPIRONE, COLACE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5512848-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 05, 2007. Female patient, weighting 192.0 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with ABRAXANE, LORATADINE, TRICOR, ZOFRAN, PRILOSEC, BUSPIRONE, COLACE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5522166-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 12, 2007. Female patient, weighting 161.6 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 10 MG/KG, QOW. During the same period patient was treated with TOPOTECAN, CHLORASEPTIC THROAT SPRAY, HEPARIN, HYDROMORPHONE, LORAZEPAM, NICOTINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5525905-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 07, 2007. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal necrosis, small intestinal obstruction. Bevacizumab dosage: unknown. During the same period patient was treated with TAXOL, CISPLATIN, APREPITANT, DEXAMETHASONE, DIPHENHYDRAMINE, DOCUSATE, CHLORIDE, PALONOSETRON. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5528252-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 21, 2007. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal necrosis, small intestinal obstruction. Bevacizumab dosage: unknown. During the same period patient was treated with TAXOL, CISPLATIN, APREPITANT, DEXAMETHASONE, DIPHENHYDRAMINE, DOCUSATE, CHLORIDE, PALONOSETRON. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5564089-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 11, 2007. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal necrosis, small intestinal obstruction. Bevacizumab dosage: 714 MG, QD. During the same period patient was treated with TAXOL, CISPLATIN, APREPITANT, DEXAMETHASONE, DIPHENHYDRAMINE, DOCUSATE, CHLORIDE, PALONOSETRON. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5620201-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 01, 2008. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with PACLITAXEL, CISPLATIN, ACETAMINOPHEN, AMBIEN, ESCITALOPRAM OXALATE, HYDROMORPHONE, IBUPROFEN, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5620204-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 01, 2008. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal necrosis, small intestinal obstruction. Bevacizumab dosage: 714 MG, QD. During the same period patient was treated with TAXOL, CISPLATIN, APREPITANT, DEXAMETHASONE, DIPHENHYDRAMINE, DOCUSATE, CHLORIDE, PALONOSETRON. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5675139-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 13, 2008. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal necrosis, small intestinal obstruction. Bevacizumab dosage: 714 MG, QD. During the same period patient was treated with TAXOL, CISPLATIN, APREPITANT, DEXAMETHASONE, DIPHENHYDRAMINE, DOCUSATE, CHLORIDE, PALONOSETRON. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5700623-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 03, 2008. Female patient, weighting 161.6 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 10 MG/KG, QOW. During the same period patient was treated with TOPOTECAN, CHLORASEPTIC THROAT SPRAY, HEPARIN, HYDROMORPHONE, LORAZEPAM, NICOTINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5850086-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 04, 2008. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: intestinal perforation, small intestinal obstruction. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient died.

Bevacizumab Side Effects Report #5888622-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 05, 2008. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: unknown. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, MEDROXYPROGESTERONE, PREMARIN, AMITRIPTYLINE, SPIRONOLACTONE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5922254-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 02, 2008. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: unknown. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, MEDROXYPROGESTERONE, PREMARIN, AMITRIPTYLINE, SPIRONOLACTONE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5968636-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 19, 2008. Female patient, weighting 145.9 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ATIVAN, CELEXA, COLACE, COMPAZINE, OMEPRAZOLE, SENNA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5483688-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 09, 2007. Male patient, 49 years of age, weighting 200.4 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea haemorrhagic, disease progression, dyspnoea, hypotension, small intestinal obstruction, west nile viral infection. Bevacizumab dosage: 10 MG QCD1 IV. During the same period patient was treated with CISPLATIN, DOCETAXEL, IRINOTECAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5608791-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 29, 2008. Male patient, 49 years of age, weighting 200.4 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, depressed level of consciousness, disease progression, dyspnoea, encephalopathy, hypotension, small intestinal obstruction, virus serology test positive. Bevacizumab dosage: 10 MG QCD1 AND8 IV. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5501313-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 18, 2007. Male patient, weighting 217.6 lb, was diagnosed with non-small cell lung cancer, metastases to central nervous system and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diverticulitis, small intestinal obstruction. Bevacizumab dosage: 1500 MG, Q3W. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6016592-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 17, 2008. Male patient, weighting 176.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB, VYTORIN, OMEPRAZOLE, METOPROLOL TARTRATE, PLAVIX, AMLODIPINE, TERAZOSIN, BENADRYL. Patient was hospitalized and became disabled. Patient died on 12/16/2008.

Bevacizumab Side Effects Report #6019768-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 19, 2008. Male patient, weighting 176.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB, VYTORIN, OMEPRAZOLE, METOPROLOL, PLAVIX, AMLODIPINE, TERAZOSIN, BENADRYL. Patient was hospitalized and became disabled. Patient died on 12/16/2008.

Bevacizumab Side Effects Report #5492369-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 10, 2007. Male patient, weighting 165.3 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, small intestinal obstruction. Bevacizumab dosage: 10 MG/M2, Q3W. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5498601-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2007. Male patient, weighting 174.2 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, febrile neutropenia, muscle spasms, nausea

, small intestinal obstruction. Bevacizumab dosage: 10MG/MG2 IV BOLUS. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5505748-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 24, 2007. Male patient, weighting 165.3 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, small intestinal obstruction. Bevacizumab dosage: 10 MG/M2, Q3W. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5827378-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 22, 2008. Male patient, weighting 334.9 lb, was diagnosed with malignant melanoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hypertension, small intestinal obstruction, vomiting. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with LORTAB, REGLAN, ALTACE, ZOFRAN, FERROUS SULPHATE, BENTYL, SUPPLEMENTS. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5879321-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 10, 2008. Male patient, weighting 332.9 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain

, diarrhoea, glioblastoma multiforme, ileus, malignant neoplasm progression, nausea

, pyrexia, small intestinal obstruction. Bevacizumab dosage: unknown. During the same period patient was treated with BORTIZOMIB, PROVIGIL, TRAZODONE, KEPPRA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5626534-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 08, 2008. Female patient was diagnosed with fallopian tube cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: rhinorrhoea, small intestinal obstruction. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PACLITAXEL, CISPLATIN, PSEUDOEPHEDRINE, ACETAMINOPHEN, AMBIEN, APREPITANT, ASPIRIN, BISACODYL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5645947-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Feb 22, 2008. Female patient was diagnosed with fallopian tube cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: rhinorrhoea, small intestinal obstruction. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PACLITAXEL, CISPLATIN, PSEUDOEPHEDRINE, ACETAMINOPHEN, AMBIEN, APREPITANT, ASPIRIN, BISACODYL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5662838-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 04, 2008. Female patient was diagnosed with fallopian tube cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: rhinorrhoea, small intestinal obstruction. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PACLITAXEL, CISPLATIN, PSEUDOEPHEDRINE, ACETAMINOPHEN, AMBIEN, APREPITANT, ASPIRIN, BISACODYL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5845824-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 06, 2008. Female patient, weighting 135.1 lb, was diagnosed with endometrial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, ATIVAN, COLACE, COMPAZINE, DEXAMETHASONE, MOTRIN, OXYCODONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5958540-X
Bevacizumab side effect was reported by a Health Professional from UNITED KINGDOM on Nov 04, 2008. Female patient was diagnosed with diffuse large b-cell lymphoma, non-hodgkin's lymphoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: lymphopenia, neutropenia, small intestinal obstruction, white blood cell count decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient recovered.

Bevacizumab Side Effects Report #5958554-X
Bevacizumab side effect was reported by a Health Professional from UNITED KINGDOM on Nov 04, 2008. Female patient was diagnosed with diffuse large b-cell lymphoma, non-hodgkin's lymphoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: lymphopenia, neutropenia, small intestinal obstruction, white blood cell count decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient recovered.

Bevacizumab Side Effects Report #5193680-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 06, 2006. Male patient, 73 years of age, weighting 183.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: adhesion

, blood potassium decreased, haematocrit decreased, haemoglobin decreased, peritoneal neoplasm, small intestinal obstruction, white blood cell count decreased. Bevacizumab dosage: 465MG IV Q 14 DAYS. During the same period patient was treated with FLUOROURACIL, CORTISONE ACETATE, FLUDRACORT, COUMADIN, CIPRO, PROSCAR. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5298468-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 09, 2007. Male patient, weighting 183.0 lb, was diagnosed with colorectal cancer metastatic, adrenal insufficiency, deep vein thrombosis

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 465 MG, Q2W. During the same period patient was treated with CETUXIMAB, FLUOROURACIL, LEUCOVORIN CALCIUM, CORTISONE ACETATE, FLUDROCORTISONE ACETATE, COUMADIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5582083-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 21, 2007. Male patient, weighting 147.7 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 548 MG, Q3W. During the same period patient was treated with CAPECITABINE, IRINOTECAN, RAMIPRIL, PROCHLORPERAZINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6121295-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 09, 2009. Female patient, weighting 159.8 lb, was diagnosed with colorectal cancer

, colon cancer, pulmonary embolism

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with LEUCOVORIN CALCIUM, FLUOROURACIL, IRINOTECAN, ENOXAPARIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5476347-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 18, 2007. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 10 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, ZOFRAN, DECADRON, KYTRIL, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5508346-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 25, 2007. Female patient, weighting 159.8 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ENOXAPARIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5550802-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 28, 2007. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 10 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, ZOFRAN, DECADRON, KYTRIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5637550-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 13, 2008. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 10 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, ZOFRAN, DECADRON, KYTRIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5720472-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 10, 2008. Male patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: myocardial infarction, small intestinal obstruction. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient died on 12/05/2006.

Bevacizumab Side Effects Report #5724169-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 10, 2008. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5740915-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 02, 2008. Male patient, weighting 147.7 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain

, intestinal obstruction, small intestinal obstruction. Bevacizumab dosage: 494 MG, Q3W. During the same period patient was treated with XELODA, METOCLOPRAMIDE, LOPERAMIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5750939-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 20, 2008. Female patient, weighting 159.8 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ENOXAPARIN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6012620-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 03, 2008. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, small intestinal obstruction. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, FOLINIC ACID, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #6001798-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Female patient was diagnosed with breast cancer

and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with VORINOSTAT, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5480892-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 27, 2007. Female patient, weighting 273.4 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Bevacizumab dosage: 10 MG/KG, Q2W. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5750032-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 20, 2008. Female patient, weighting 159.8 lb, was diagnosed with colon cancer, pulmonary embolism

Bevacizumab and small intestinal obstruction

SideEffects101.com

Bevacizumab and small intestinal obstruction Patient Reports February 10, 2012

side effects of Bevacizumab